Click here to get the latest information on the coronavirus (COVID-19) from Texas HHS.

GENERESS FE CHEWABLE TABLET

Drug Details

General

Brand Name: GENERESS FE CHEWABLE TABLET
Generic Name: noreth-ethinyl estradiol/iron
Manufacturer: ALLERGAN INC.
NDC: 00023603003
Package size: 28EA
Family Planning drug: Yes
Diabetic Supply Drug: No
HTW drug: Yes
HTWPlus drug: No
Long-acting reversible contraception product: No
Refill-to-soon Utilization*: 75%

Drug Pricing

Retail Pharmacy Cost: 5.72658
Retail Pharmacy Eff Date: 01/28/2020
Specialty Pharmacy Cost: 5.37597
Specialty Pharmacy Eff Date: 01/28/2020
Long-term Care Pharmacy Cost: 5.64477
Long-term Care Pharmacy Eff Date: 01/28/2020
340B Cost: 2.51268
Premium Preferred Generic Incentive†: Yes

* Impacts only claims paid by the Vendor Drug Program: traditional Medicaid, CSHCN, HTW, and KHC Programs.

† Refer to the Pricing and Reimbursement chapter of the Pharmacy Provider Procedure Manual for information about traditional Medicaid claim pricing and PPG pricing incentives.

‡ Refer to the Clinical Prior Authorization Assistance Chart (PDF) for the list of clinical prior authorization each MCO uses and how those authorizations relate to those used in traditional Medicaid. Refer to the MCO Resources page for links to each MCO’s clinical prior authorizations.

Program Coverage

Medicaid

Effective date: 04/09/2019
PDL PA Required: No
FFS Clinical PA Required‡: No
Compound-only use: No

CHIP

Effective date: 04/09/2019
Compound-only use: No

CSHCN

Effective date: 04/09/2019
Compound-only use: No
Comments: Refer to program requirements

HTW

Effective date: 09/04/2019

‡ Please review the lists of DUR board-approved clinical prior authorizations that apply to traditional Medicaid and those that health plans may use. The Pharmacy Clinical Prior Authorization Assistance Chart (PDF) shows the prior authorization each health plan uses and how those authorizations relate to the authorizations used for traditional Medicaid claim processing. Refer to the MCO Resources for links to each health plan's active clinical prior authorizations.